Thistlethwaite JR - Search Results

1

OKT3 F(ab')2 fragments--retention of the immunosuppressive properties of whole antibody with marked reduction in T cell activation and lymphokine release.

Woodle ES, Thistlethwaite JR, Ghobrial IA, Jolliffe LK, Stuart FP, Bluestone JA. Woodle ES, et al. Among authors: thistlethwaite jr. Transplantation. 1991 Aug;52(2):354-60. doi: 10.1097/00007890-199108000-00033. Transplantation. 1991. PMID: 1908148

2

Humanized OKT3 antibodies: successful transfer of immune modulating properties and idiotype expression.

Woodle ES, Thistlethwaite JR, Jolliffe LK, Zivin RA, Collins A, Adair JR, Bodmer M, Athwal D, Alegre ML, Bluestone JA. Woodle ES, et al. Among authors: thistlethwaite jr. J Immunol. 1992 May 1;148(9):2756-63. J Immunol. 1992. PMID: 1533410

3

Effect of a single amino acid mutation on the activating and immunosuppressive properties of a "humanized" OKT3 monoclonal antibody.

Alegre ML, Collins AM, Pulito VL, Brosius RA, Olson WC, Zivin RA, Knowles R, Thistlethwaite JR, Jolliffe LK, Bluestone JA. Alegre ML, et al. Among authors: thistlethwaite jr. J Immunol. 1992 Jun 1;148(11):3461-8. J Immunol. 1992. PMID: 1534096

4

Anti-CD3 monoclonal antibody therapy. An approach toward optimization by in vitro analysis of new anti-CD3 antibodies.

Woodle ES, Thistlethwaite JR, Jolliffe LK, Fucello AJ, Stuart FP, Bluestone JA. Woodle ES, et al. Among authors: thistlethwaite jr. Transplantation. 1991 Aug;52(2):361-8. Transplantation. 1991. PMID: 1714644

5

T-cell activation and lymphokine production induced by antihuman CD3 monoclonal antibodies.

Woodle ES, Thistlethwaite JR, Jolliffe LK, Ghobrial I, Fuccello AJ, Stuart FP, Bluestone JA. Woodle ES, et al. Among authors: thistlethwaite jr. Transplant Proc. 1991 Feb;23(1 Pt 1):81-2. Transplant Proc. 1991. PMID: 1824999 No abstract available.

6

OKT3 therapy for hepatic allograft rejection. Differential response in adults and children.

Woodle ES, Thistlethwaite JR Jr, Emond JC, Whitington PF, Black DD, Aran PP, Baker AL, Stuart FP, Broelsch CE. Woodle ES, et al. Among authors: thistlethwaite jr jr. Transplantation. 1991 Jun;51(6):1207-12. doi: 10.1097/00007890-199106000-00012. Transplantation. 1991. PMID: 1904662

7

OKT3 therapy for hepatic allograft rejection: comparison of results in adults and children.

Woodle ES, Thistlethwaite JR Jr, Emond JC, Whitington PF, Black DD, Aran PP, Baker AL, Stuart FP, Broelsch CE. Woodle ES, et al. Among authors: thistlethwaite jr jr. Transplant Proc. 1990 Aug;22(4):1765-6. Transplant Proc. 1990. PMID: 2117803 No abstract available.

8

Activation of human T cells in vivo following treatment of transplant recipients with OKT3.

Ellenhorn JD, Woodle ES, Ghobreal I, Thistlethwaite JR, Bluestone JA. Ellenhorn JD, et al. Among authors: thistlethwaite jr. Transplantation. 1990 Oct;50(4):608-12. doi: 10.1097/00007890-199010000-00016. Transplantation. 1990. PMID: 2145669

9

T lymphocyte activation following OKT3 treatment.

Ellenhorn JD, Woodle ES, Thistlethwaite JR, Bluestone JA. Ellenhorn JD, et al. Among authors: thistlethwaite jr. Curr Surg. 1990 Nov-Dec;47(6):458-9. Curr Surg. 1990. PMID: 2279409 No abstract available.

10

Reexposure to OKT3 in renal allograft recipients.

Mayes JT, Thistlethwaite JR Jr, Stuart JK, Buckingham MR, Stuart FP. Mayes JT, et al. Among authors: thistlethwaite jr jr. Transplantation. 1988 Feb;45(2):349-53. Transplantation. 1988. PMID: 3278428

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters